Flu vaccine only 23 percent effective this season
the ONA take:
In early January, the Centers for Disease Control and Prevention (CDC) issued a report that supports earlier findings, stating that the efficacy of this year's flu vaccine is low.
A CDC analysis of 2, 321 adults and children with acute respiratory illness found that 41% carried the virus, with 96% having influenza A and the remaining 4% influenza B. Based on this, the CDC estimates that this year's vaccine has reduced an individual's chances of a flu-related doctor visit by 23%.
A reason for the low efficacy could be due to the fact that 70% of this season's H3N2 viruses have been categorized as "drift variants"—viruses that are genetically different from the strains used to make this season's vaccine.
Approximately 96% of the individuals found in the CDC test to have the flu had influenza A, which are all H3N2 viruses. Vaccine effectiveness against the H3N2 viruses appeared to be greatest amongst the young, with children and teenagers of age 6 months through 17 years showing 26% effectiveness.
Rates of effectiveness were lower for adults 50 years old or older, at 14%, and lower still for the middle demographic of adults of age 18-49, at 12%. H3N2 viruses result in the higher number of hospitalizations and deaths.
Based on this report, the CDC urges all individuals at high risk for flu-related complications to seek out treatment immediately if influenza type symptoms are experienced. The Cdv still recommends that all individuals 6 months of age or older get vaccinated, as the vaccine still protects some people and could also protect against other viruses that may appear at a later date.
The CDC issued a report that supports earlier findings, stating that the efficacy of this year's flu vaccine is low.
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Risk of Second Cancers Increased in Hodgkin Lymphoma Survivors
- Directly Informing Patients of Breast Cancer Risk, Options Improves Follow-Up Screening
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Free Lung Cancer Screening Findings Support Continual Screenings in High-Risk Populations
- Parental Self-persuasion in Low-Income Groups Improves HPV Vaccination Rates
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Shared Decision-making Visits Improved Comfort With Lung Cancer Screening Decisions
- Temozolomide With Radiotherapy for Glioblastoma Provides Some Survival Benefit in Elderly
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|